This study was done to evaluate the antibacterial activity of chloramphenicol eye drops after exposure to sunlight as well as to measure the percentage of drug content. Chloramphenicol eye drops manufactured by four different companies were collected from local market and exposed to sunlight and their antimicrobial activity was determined against Salmonella typhi and Staphylococcus aureus. Each product was exposed to sunlight for fourteen hours in three different ways with or without of their packaging. The percentage of chloramphenicol contents in eye drop samples was also measured by UV-spectrophotometric method. Significant differences in the inhibitory zones were observed among different set of samples. An inverse correlation between percentage of chloramphenicol content and their antibacterial activity was observed. The results indicate that the UVspectrophotometric method cannot distinguish between chloramphenicol and its degraded products and thus gives incorrect high values of drug content in the preparations, therefore, it should not be considered as an appropriate method to analyze chloramphenicol preparation with its degradation products.
Introduction
Chloramphenicol (MF: C 11 H 12 C l2 N 2 O 5 , MW: 323.1) is a broad spectrum antibiotic which is effective against a wide range of gram-negative and gram-positive organisms (Lawrence, 1987) . It is still widely used as eye drops for the treatment of bacterial conjunctivitis caused by Escherichia coli, Haemophilus influenzae, Staphylococcus aureus, Streptococcus haemolyticus, Morax-Axenfield and others. Chloramphenicol is also indicated in typhoid fever, various salmonella infections, anaerobic infections with Bacteroides fragilis, rickettsial infections, and bacterial meningitis. It has been the drug of choice for the treatment of H. injluenzae meningitis, especially if the organism is a B-Lactarnase producer (Turk, 1977 , Martindale, 1989 .
Chloramphenicol is highly sensitive to light and photochemical decomposition of chloramphenicol results in a yellowing of the solution, development of an orange-yellow precipitate and lowering of the pH (Martindale, 1989) . The chemistry of the photo-degradation products of chloramphenicol aqueous solution at room temperature (21-30ºC) and in the presence of sunlight, suggest that under the influence of light and water the drug undergoes oxidation, reduction and condensation reactions. The photochemical degradation of chloramphenicol in various solvents was investigated and the following photolysis products isolated: hydrochloric acid, 4-nitrobenzaldehyde, 4-nitrobenzoic acid, 4,4-azoxybenzoic acid and 2-amino-1-(4-nitrophenyl) propane-1,3-diol, as indicated by thin layer chromatography (Shih, 1971) . Later work concerning the quality control of a pharmaceutical preparation (0.24% eye drops), it has found that under the influence of sunlight, some nitrosocompounds: p-nitrobenzene, p-nitrobenzaldehyde and pnitrosobenzoic acid are formed.
In this article we show for the first time that antimicrobial activity was decreased in the sunlight -induced degradation of chloramphenicol preparations whereas the concentrations of chloramphenicol were increased significantly compared to control when the content was analyzed by UVspectrophotometric method. The results of this study suggest that UV-spectrophotometric method may lead to incorrect results as the degraded products of chloramphenicol also absorb UV radiation around the same wavelength. 
Materials and Methods

Materials:
The chloramphenicol 0.5% eye drops of four different companies (A, B, C and D) were collected from local market of Rajshahi City. Sterilized filter paper discs (6 mm) and commercially available nutrient agar medium were purchased from the local suppliers of DIFCO and BBL (U.S.A). All the reagents used were of analytical grades. A double beam spectrophotometer UV-3600 (Shimadzu Corporation, Japan) was used to take Spectrophotometric readings. Experimental design and preparation and treatment of samples with sunlight and heat: A 3 ml aliqout of the four different samples (commercial preparations of 0.5% chloramphenicol eye drops, A, B, C and D) were used in this study. Each preparation was divided into four different sets and exposed to sunlight for 14 hours in divided days: Set-1: Sample (3ml) stored in refrigerator with their containers (control).
Set-2: Sample (3ml) exposed to sunlight with their primary and secondary packaging (container + carton).
Set-3: Sample (3ml) exposed to sunlight with their container only (primary packaging).
Set-4: Sample (3 ml) exposed to sunlight in clear transparent glass test tubes (direct exposure).
Monitoring of change in color and determination of antimicrobial activity of sunlight-treated samples:
The change in the appearance after sunlight-induced degradation of chloramphenicol preparations was noted before and after of exposure. The antibacterial activity of sunlight-treated chloramphenicol (0.5%) eye drops were evaluated by the disc diffusion method against two bacteria -Staphylococcus aureus and Salmonella Typhi (Bauer, 1966) at 30 g/disc. For preparation of 30 µg/discs of chloramphenicol preparations, 6 µl of each solution were taken by a 10 µl micropipette in an aseptic condition. The discs were placed on test organism seeded plates. The activity was determined after 24 hours of incubation at 37 0 C. The diameter of the zone was measured with a transparent scale in mm.
Analysis of chloramphenicol content in the samples by UV-Spectroscopic method:
The potency of heat-induced degraded chloramphenicol aqueous solution was determined using UV-spectrophotometric method. 2 ml solution (10 mg equivalent of chloramphenicol) from each preparation were taken in 100 ml measuring cylinder. Then 50 ml of distilled water were added and stirred for 5 minutes. The total volume was made up to 100 ml with the same solvent and mixed well. 10 ml solution was transferred in another 100 ml measuring cylinder and the volume was adjusted with the same solvent. The absorbance of the assay preparation was taken at 278 nm wavelength in a UV-Spectrophotometer and the results are recorded and percentage of drug content was calculated.
Results and Discussion
Change in appearance and antibacterial activity after exposure to sun: Before exposure to sun the appearances of all the samples of different sets were clear and colorless. After 14 hours exposure of sunlight the color of all samples of Set-2 turned into opaque except the sample from D retained its original color. In case of Set-3, the color of all of the sample solutions turned into light yellow to deep yellow (Table 1 ). The results suggest that packaging is very important factor for the stability of chloramphenicol 0.5% eye drops. The color of the set-2 samples did not change significantly because of protection of light by the secondary packaging (carton). On the other hand, the container alone is not enough to protect the sunlight which is evident by the production of colored degradation products in most of the samples in Set -3. The change in appearance of the samples in Set-4 was most prominent and all of the preparations turned to deep yellow.
The zone of inhibition of Set -2, Set -3 and Set -4 samples were compared to that of Set-1 after exposure to sunlight against Salmonella Typhi and Staphylococcus aureus and the results are shown in Table 1 . It is evident that the antibacterial activity decreased from Set-1 to Set-4 ( Figure-1 and Figure 2 ). The measured zone of inhibition of Set-1, Set-2, Set-3 and Set-4 of product B against S. aureus was 21.27, 20.19, 19.92 and 17.75, respectively. The percentage decrease of activity of Set-4 with respect to Set-1 was 16.54% against S. aureus. We have observed the almost similar trend in other two products C and D. In a previous study it was observed that inadequate refrigeration and prolonged shelf lives of chloramphenicol generics collected in India were associated with very high levels of chloramphenicol thermal breakdown product, 2-amino-1-(4-nitrophenyl) propane-1,3-diol, when compared with drops stored in proper (Serrano, 2004) . Values are expressed as mean ± SD of three replicate Where, Set-1: sample stored in refrigerator with their containers (control); Set-2: sample exposed to sunlight with their container and carton, Set-3: sample exposed to sunlight with their container only; Set-4: sample exposed to sunlight in clear transparent glass test tubes (direct exposure).
Change in percentage of drug content after exposure to sun: In all cases the measured percentage of drug content in the control samples were more than 100%. When the samples were treated with sunlight for around 14 hours, the percentage drug content was increased. For example, the % content of chloramphenicol in the Set-1 of the product B was 108.42%. After exposure to sunlight the values increased from S-2 to Set-4. The % drug content in the Set-2, Set-3 and Set-4 was measured as 110.77, 112.50 and 140.40%, respectively (Table-1, Figure-1 ). More importantly, the increase of % of chloramphenicol content of Set-2, Set-3 of product A compared to control (Set-1) was 5.08% and 8.36% respectively whereas for Set-4 the value increased up to 23.38%. The UVabsorption spectrum of eye drops after exposure to sun exhibited a hypsochromic shift. The λmax of chloramphenicol before treatment (Standard) was 278 nm whereas the λmax of sunlight-treated samples was found to be at 274 nm. The absorption spectrum also showed a hyperchromic effect i.e. the absorption intensity also increases after sunlight degradation (Figure 3) . The change in the zones of inhibition and percentage of decrease in efficacy of sunlight-induced authentic chloramphenicol solutions also showed the same trend as to the sunlight treated eye drop samples (data not shown). Aboshiha (2008) observed that as the chloramphenicol eye-drop not stored in refrigerator in the hot season of May, 2005 when the temperature was around 40ºC became ineffective with presumed resistance of microbial infections (often in the absence of microbiological sensitivity data). The present microbiological study determining the loss of efficacy of the chloramphenicol eye drops strongly supports the previous findings.
Conclusion
An inverse correlation between the estimated drug content and the antibacterial activity was found which indicates that the chloramphenicol in the preparations exposed to sunlight are degraded and produced a colored compound responsible for higher absorbance in the specified wavelength (278nm). The results suggest that in spite of being less expensive, pharmaceutical companies should not use the UV-spectroscopic method to analyze chloramphenicol.
High Performance Liquid Chromatography (HPLC) as suggested by BP and USP should be followed for the analysis. Moreover, a costeffective and easy method like microbial assay method should be developed to assay the chloramphenicol content in the preparations which can be used by the middle-sized pharmaceutical industries who are not able to afford high cost equipments like HPLC. Thus, any chemical compounds that have degradation products having the UV absorption around the same λ-max of parent compound cannot be assayed by UV-spectrophotometric method. Microbiological assay must be performed to analyze the potency of antibacterial compounds like chloramphenicol.
